Oncoshot
Healthcare Software · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
67 Ayer Rajah Cres 02-10, Singapore, Cen...Website
www.oncoshot.comRevenue
<$5 MillionIndustry
About Oncoshot
Oncoshot Org Chart
Is Oncoshot your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Oncoshot
Check out if Oncoshot is spiking on competitors!
Oncoshot, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Oncoshot had a recent Job posting/layoffs
Check if Oncoshot has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Oncoshot launches new products
Earning: See what the market has to say on Oncoshot recently announced quarterly report
Funding: Get notified immidiatlly once Oncoshot has new funding data
Recommended Actions
Reach out to Masked Content who joined Oncoshot as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Oncoshot is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Oncoshot is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Oncoshot.
Oncoshot Tech Stack
A closer look at the technologies used by Oncoshot
Oncoshot News & Media
Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered Drug Development in China
SINGAPORE, Dec. 22, 2023 /PRNewswire/ -- Oncoshot, an innovative health insights exchange platform leveraging AI and federated learning, today announced it has forged a strategic partnership with Zhejiang Ablaze Medicine, a leading service provider of end-to-end clinical trial solutions, to jointly pioneer AI-led innovations to transform the speed, efficiency, accessibility of global drug development programs. This collaboration brings together complementary strengths - Oncoshot's capabilities iInnovative Collaboration: Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan
SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specialises in clinical trial site recruitment and retention and project...Innovative Collaboration: Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan
SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specialises in clinical trial site recruitment and retention and project management solutions, while the latter operates a cutting-edge real-time health insights exchange platform. Mr Taketeru Inokawa (left) and Dr Huren Sivaraj (right) during the MOU signing ceremony in Singapore. TheOncoshot and Novotech Partner to Offer Cancer Data Insights
SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Oncoshot and internationally recognised contract research organisation (CRO) Novotech have begun a partnership to enhance clinical trial management success. This collaborative partnership will grant exchange and insights into real-time population data between both organisations and their affiliated leading cancer research centres. Novotech, the leading Asia-Pacific biotech specialist CRO, presently has offices in 11 geographies across the region, and site
Top Healthcare Software Companies
Frequently Asked Questions Regarding Oncoshot
A private company headquartered in Singapore, Oncoshot helps patients, caregivers and oncologists in a fast-changing landscape of cancer care identify cancer clinical trials more efficiently and effectively. Its mission is to empower patients to take control of their treatment journey and expand their options, as well as accelerate cancer trials by... Read More